查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞健康篩查市場規模、份額和趨勢分析報告：按測試類型（單測試面板、多測試面板）、樣品類型（血液、尿液）、採樣地點、地區、細分市場，2022-2030 年
市場調查報告書
商品編碼
1133327

細胞健康篩查市場規模、份額和趨勢分析報告：按測試類型（單測試面板、多測試面板）、樣品類型（血液、尿液）、採樣地點、地區、細分市場，2022-2030 年

Cellular Health Screening Market Size, Share & Trends Analysis Report By Test Type (Single Test Panels, Multi-test Panels), By Sample Type (Blood, Urine), By Collection Site, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

細胞健康篩查市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球細胞健康篩查市場規模預計將達到 56.2 億美元，從 2022 年到 2030 年以 9.2% 的複合年增長率增長。日益老齡化的人口以及隨之而來的對細胞健康診斷需求的增加正在顯著推動市場。此外，越來越多地採用直接面向消費者的方法，健康預期壽命 (HALE) 的重要性日益增加，端粒性能計劃的增加以過上健康的生活，以及政府對預防醫學日益增長的興趣正在推動市場。

越來越多的人正在接受細胞健康篩查測試，例如端粒測試，以了解細胞衰老的生物標誌物，預計也將補充市場增長。已經證明，提供端粒長度和活動信息的測試也可以提供有關生活方式和壓力源的信息。大量研究表明，急性和慢性壓力都會加速細胞老化。因此，這些測試在了解健康狀況方面發揮著重要作用。

通過研究運動、睡眠、心理健康問題、飲酒和吸煙習慣如何以不同方式改變細胞衰老，可以進一步了解細胞質量。端粒測試提供了對代謝和遺傳疾病的洞察，使臨床醫生能夠進行早期診斷並快速、個性化地調整患者治療策略。因此，對細胞篩選和擴大研究的興趣日益增加，增加了對試劑盒和測試的需求，推動了近年來的市場增長。

預防醫學應用和了解端粒長度與衰老之間的關係越來越需要細胞篩選研究。隨著時間的推移，通常建議使用基於生物細胞的篩查，以便患者可以比較結果並了解需要進行哪些校正。通過在篩查過程中監測細胞健康的變化，可以快速調整健康方案以改善整體疾病管理。

此外，與年齡有關的疾病與功能失調的舊細胞的積累有關。最近的研究表明，這些可以通過採用多種細胞健康方式來恢復，如幾項動物研究所示。因此，在蛋白質表達、蛋白質組學和基因組學領域正在進行的研發活動有望在不久的將來進一步推動對細胞健康篩查產品的需求。

細胞健康診斷市場報告亮點

按檢驗類型分，2021年單一檢驗面板佔比最大。這是由於高特異性、易於定制和改進的產品在市場上的可用性。

在單一測試面板細分市場中，氧化壓力測試將在 2021 年佔據最大份額。這些測試有助於癌症、呼吸系統疾病、糖尿病、心血管疾病和其他疾病。

根據樣本類型，2021年血液樣本部分佔最大份額。傳染病發病率的增加、新病原體的出現、對獻血的需求增加以及獻血數量的增加，導致對用於細胞健康篩查的血液樣本的需求不斷增加。

從收集地點來看，醫院將在 2021 年佔據最大的銷售額份額。很大一部分普通人群使用這些長期設施來診斷、治療和管理疾病，從而推動了這一細分市場。

2021年，北美將佔據最大的市場份額。健康預期壽命 (HALE) 的重要性日益提高以及政府針對預防性醫療保健的舉措越來越多，這些都是有望推動該地區市場增長的一些關鍵因素。

預計亞太地區將在預測期內增長最快。端粒功能計劃的傳播和意識以及對健康預期壽命的日益提高的意識正在促進該地區的增長。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
  • 市場定義
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息和第三方觀點
    • 初步調查
  • 信息分析
    • 數據分析模型
  • 市場形成和數據可視化
  • 驗證和發布數據

第二章執行摘要

  • 市場展望
  • 分部展望
  • 競爭考慮

3. 細胞健康篩查市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
      • 增加端粒性能計劃的採用以過上健康的生活
      • 健康調整後預期壽命 (HALE) 的重要性日益增加
      • 政府對預防保健的興趣日益濃厚
      • 不斷增長的老年人口導致對細胞健康篩查的需求增加
      • 增加調查活動
      • 越來越多地採用直接面向消費者的方法來提供套件
      • 慢性病負擔加重
    • 市場約束分析
      • 樣品運輸問題
      • 各公司提供的檢測試劑盒價格差異
    • 行業挑戰
    • COVID-19 影響分析
  • 細胞健康篩查市場分析工具
    • 行業分析 - 搬運工
      • 供應商力量
      • 買方議價能力
      • 替代威脅
      • 來自新進入者的威脅
      • 競爭對手之間的競爭
    • PESTEL 分析
      • 政局
      • 環境狀況
      • 社會局勢
      • 科技景觀
      • 法律狀況

第 4 章細胞健康篩查市場 - 競爭分析

  • 主要市場參與者的最新發展和影響分析
  • 供應商情況
    • 按地區/國家劃分的主要供應商/分銷商/製造商列表
  • 上市公司
    • 公司市場分析
    • 競爭儀錶盤分析
  • 民營企業
    • 主要初創企業名單
    • 區域網絡圖
    • 公司市場分析

5 細胞健康篩查市場：測試類型估計和趨勢分析

  • 定義和範圍
  • 測試類型市場份額分析，2021 年和 2030 年
  • 細分儀表板
  • 2018-2030 年按測試類型劃分的全球細胞健康篩查市場
  • 市場規模和預測，趨勢分析，2018-2030
    • 單試板
      • 端粒測試
      • 氧化應激測試
      • 炎症試驗
      • 重金屬測試
    • 多試板

6 細胞健康篩查市場：樣本類型估計和趨勢分析

  • 定義和範圍
  • 樣本類型市場份額分析，2021 年和 2030 年
  • 細分儀表板
  • 2018-2030年全球細胞健康篩查市場樣本類型
  • 市場規模和預測，趨勢分析，2018-2030
    • 血液
    • 唾液
    • 血清
    • 尿

7 細胞健康篩查市場：收集站點的估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年收集站點市場份額分析
  • 細分儀表板
  • 2018-2030 年按收集站點劃分的全球細胞健康篩查市場
  • 市場規模和預測，趨勢分析，2018-2030
    • 房子
    • 辦公室
    • 醫院
    • 診斷實驗室

第 8 章細胞健康篩查市場：區域估計和趨勢分析

  • 區域市場快照
  • 2021年區域市場份額
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2021年按國家/地區分列的市場份額分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
      • 俄羅斯
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 新加坡
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
  • SWOT 因素分析（政治與法律、經濟與技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場規模和預測，趨勢分析，2021 年和 2030 年
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
      • 俄羅斯
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 新加坡
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第九章公司簡介

  • 公司簡介
    • Telomere Diagnostics
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • SpectraCell Laboratories
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Life Length
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Repeat Diagnostics, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Cell Science Systems Corp.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Quest Diagnostics
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • LabCorp Holdings
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • OPKO
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Genova Diagnostics
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Immunodiagnostik AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • DNA Labs
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-3-68038-972-2

Cellular Health Screening Market Growth & Trends:

The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market. In addition, the rising adoption of the direct-to-consumer approach, the growing importance of healthy life expectancy (HALE), increasing telomere performance programs for leading a healthy life, and rising government focus on preventive healthcare are expected to drive the market.

An increasing number of individuals undergoing cellular health screening testing, such as telomere tests, to learn about the biomarkers of cell aging is also anticipated to supplement the market growth. It has been demonstrated that tests that provide information on telomere length and activity can also provide information on lifestyle and stress factors. Numerous studies have demonstrated that both acute stress and chronic stress accelerate cell aging. Thus, these tests play an important role in understanding one's health.

Additionally, researchers can gain insights into cellular qualities by studying how physical exercise, sleep, mental health issues, alcohol use, and smoking habits alter cellular aging in various ways. The utilization of telomere tests offers insights into metabolic and genetic illnesses, enabling clinicians to make an early diagnosis and quickly and individually tailor a patient's treatment regimen. Consequently, growing interest in cellular screening and expanding research have increased kit and test demand, facilitating market growth in recent years.

The necessity for cellular screening research has grown as a result of its many applications in preventive medicine and the capacity to comprehend relationships between telomere length and aging. Bio-cell-based screenings are frequently advised throughout time, allowing patients to compare results and comprehend what modifications need to be made. Monitoring these alterations in cellular health between screenings enables quick adjustments to be made in terms of health protocols and a general improvement in illness management.

Furthermore, disorders related to aging are linked to the buildup of old, dysfunctional cells. As shown in several animal trials, research has recently established that these can be reversed by employing a variety of cellular health procedures. Consequently, it is anticipated that ongoing research and development activities in the disciplines of protein expression, proteomics, and genomics are anticipated to further boost the demand for cellular health screening products in the near future.

Cellular Health Screening Market Report Highlights:

  • By test type, single test panels held the largest share in 2021. This is attributed to high specificity, easy customization, and increasing product availability in the market
  • In the single test panels segment, the oxidative stress tests captured the largest share in 2021. These tests aid in cancer, respiratory diseases, diabetes, cardiovascular diseases, and other diseases
  • Based on sample type, the blood sample segment accounted for the largest share in 2021. The growing incidence of infectious diseases, emergence of newer pathogens, increasing demand for donated blood, and rising number of blood donations have contributed to the rising demand for blood samples for cellular health screening
  • By collection site, hospitals captured the largest revenue share in 2021. A major part of the general population relies on these long-term facilities for diagnosis, treatment, and management of diseases, thus driving the segment
  • North America accounted for the largest market share in 2021. An increase in the importance of Healthy Life Expectancy (HALE) and increasing number of government initiatives focused on preventive healthcare are some of the key factors expected to boost the market growth in the region
  • Asia Pacific is expected to witness the fastest growth throughout the forecast period. Improving adoption and awareness of telomere performance programs and growing awareness of healthy life expectancy have contributed to regional growth

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Cellular Health Screening Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Rise in the adoption of telomere performance programs to lead a healthy life
      • 3.3.1.2 Increase in importance of health-adjusted life expectancy (HALE)
      • 3.3.1.3 Increasing government focus on preventive healthcare
      • 3.3.1.4 Rise in geriatric population leading to growth in the need for cellular health screening
      • 3.3.1.5 Increase in research activities
      • 3.3.1.6 Growth in the adoption of direct-to-consumer approach for the availability of kits
      • 3.3.1.7 Rise in burden of chronic diseases
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Problems associated with the transport of samples
      • 3.3.2.2 Differences in the cost of test kits offered by different companies
    • 3.3.3 Industry challenges
    • 3.3.4 COVID-19 Impact Analysis
  • 3.4 Cellular Health Screening Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal Landscape

Chapter 4 Cellular Health Screening Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of Major Suppliers/Distributors/Manufacturers, By Region/Country
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Cellular Health Screening Market: Test Type Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Test Type Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Cellular Health Screening Market, by Test Type, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Single Test Panels
      • 5.5.1.1 Single Test Panels Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.2 Telomere Tests
      • 5.5.1.2.1 Telomere Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.3 Oxidative Stress Tests
      • 5.5.1.3.1 Oxidative Stress Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.4 Inflammation Tests
      • 5.5.1.4.1 Inflammation Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.5 Heavy Metals Tests
      • 5.5.1.5.1 Heavy Metals Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 5.5.2 Multi-test Panels
      • 5.5.2.1 Multi-test Panels Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6 Cellular Health Screening Market: Sample Type Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Sample Type Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Cellular Health Screening Market, by Sample Type, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Blood
      • 6.5.1.1 Blood Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2 Saliva
      • 6.5.2.1 Saliva Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.3 Serum
      • 6.5.3.1 Serum Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.4 Urine
      • 6.5.4.1 Urine Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7 Cellular Health Screening Market: Collection Site Estimates And Trend Analysis

  • 7.1 Definition & Scope
  • 7.2 Collection Site Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Cellular Health Screening Market, by Collection Site, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Home
      • 7.5.1.1 Home Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.2 Office
      • 7.5.2.1 Office Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.3 Hospital
      • 7.5.3.1 Hospital Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.4 Diagnostic Labs
      • 7.5.4.1 Diagnostic Labs Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8 Cellular Health Screening Market: Regional Estimates & Trend Analysis

  • 8.1 Regional Market Snapshot
  • 8.2 Regional Market Share, 2021
    • 8.2.1 North America
    • 8.2.2 Europe
    • 8.2.3 Asia Pacific
    • 8.2.4 Latin America
    • 8.2.5 Middle East & Africa
  • 8.3 Market Share Analysis by Country, 2021
    • 8.3.1 North America
      • 8.3.1.1 U.S.
      • 8.3.1.2 Canada
    • 8.3.2 Europe
      • 8.3.2.1 U.K.
      • 8.3.2.2 Germany
      • 8.3.2.3 Spain
      • 8.3.2.4 France
      • 8.3.2.5 Italy
      • 8.3.2.6 Russia
    • 8.3.3 Asia Pacific
      • 8.3.3.1 Japan
      • 8.3.3.2 China
      • 8.3.3.3 India
      • 8.3.3.4 South Korea
      • 8.3.3.5 Singapore
      • 8.3.3.6 Australia
    • 8.3.4 Latin America
      • 8.3.4.1 Brazil
      • 8.3.4.2 Mexico
      • 8.3.4.3 Argentina
    • 8.3.5 Middle East & Africa
      • 8.3.5.1 South Africa
      • 8.3.5.2 Saudi Arabia
      • 8.3.5.3 UAE
  • 8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 8.4.1 North America
    • 8.4.2 Europe
    • 8.4.3 Asia Pacific
    • 8.4.4 Latin America
    • 8.4.5 Middle East & Africa
  • 8.5 Market Size & Forecasts, and Trend Analysis, 2021 & 2030
    • 8.5.1 North America
      • 8.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.1.2 U.S.
      • 8.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.1.2.3 U.S. Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.1.3 Canada
      • 8.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.1.3.3 Canada Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.2 Europe
      • 8.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.2.2 U.K.
      • 8.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.2.3 U.K. Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.3 Germany
      • 8.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.3.3 Germany Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.4 Spain
      • 8.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.4.3 Spain Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.5 France
      • 8.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.5.3 France Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.6 Italy
      • 8.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.6.3 Italy Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.7 Russia
      • 8.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.7.3 Russia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.3 Asia Pacific
      • 8.5.3.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.3.2 Japan
      • 8.5.3.2.1 Japan Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.2.2 Japan Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.2.3 Japan Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.3 China
      • 8.5.3.3.1 China Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.3.2 China Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.3.3 China Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.4 India
      • 8.5.3.4.1 India Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.4.2 India Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.4.3 India Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.5 South Korea
      • 8.5.3.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.5.3 South Korea Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.6 Singapore
      • 8.5.3.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.6.3 Singapore Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.7 Australia
      • 8.5.3.7.1 Australia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.7.2 Australia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.7.3 Australia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.4 Latin America
      • 8.5.4.1 Latin America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.4.2 Brazil
      • 8.5.4.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.2.3 Brazil Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.4.3 Mexico
      • 8.5.4.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.3.3 Mexico Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.4.4 Argentina
      • 8.5.4.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.4.3 Argentina Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.5 Middle East & Africa
      • 8.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.5.2 South Africa
      • 8.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.2.3 South Africa Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.5.3 Saudi Arabia
      • 8.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.3.3 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.5.4 UAE
      • 8.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.4.3 UAE Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)

Chapter 9 Company Profile

  • 9.1 Company Profiles
    • 9.1.1 Telomere Diagnostics
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 SpectraCell Laboratories
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 Life Length
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 Repeat Diagnostics, Inc.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 Cell Science Systems Corp.
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 Quest Diagnostics
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 LabCorp Holdings
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.1.8 OPKO
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product benchmarking
      • 9.1.8.4 Strategic initiatives
    • 9.1.9 Genova Diagnostics
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product benchmarking
      • 9.1.9.4 Strategic initiatives
    • 9.1.10 Immunodiagnostik AG
      • 9.1.10.1 Company overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product benchmarking
      • 9.1.10.4 Strategic initiatives
    • 9.1.11 DNA Labs
      • 9.1.11.1 Company overview
      • 9.1.11.2 Financial Performance
      • 9.1.11.3 Product benchmarking
      • 9.1.11.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 4 North America cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 5 North America cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 6 North America cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 7 North America cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 8 U.S. cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 9 U.S. cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 10 U.S. cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 11 U.S. cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 12 Canada cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 13 Canada cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 14 Canada cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 15 Canada cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 16 Europe cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 17 Europe cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 18 Europe cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 19 Europe cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 20 Europe cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 21 Germany cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 22 Germany cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 23 Germany cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 24 Germany cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 25 U.K. cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 26 U.K. cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 27 U.K. cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 28 U.K. cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 29 France cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 30 France cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 31 France cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 32 France cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 33 Spain cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 34 Spain cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 35 Spain cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 36 Spain cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 37 Italy cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 38 Italy cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 39 Italy cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 40 Italy cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 41 Russia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 42 Russia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 43 Russia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 44 Russia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 45 Asia Pacific cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 46 Asia Pacific cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 47 Asia Pacific cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 48 Asia Pacific cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 49 Asia Pacific cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 50 Japan cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 51 Japan cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 52 Japan cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 53 Japan cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 54 China cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 55 China cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 56 China cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 57 China cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 58 India cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 59 India cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 60 India cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 61 India cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 62 South Korea cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 63 South Korea cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 64 South Korea cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 65 South Korea cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 66 Singapore cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 67 Singapore cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 68 Singapore cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 69 Singapore cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 70 Australia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 71 Australia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 72 Australia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 73 Australia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 74 Latin America cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 75 Latin America cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 76 Latin America cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 77 Latin America cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 78 Latin America cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 79 Brazil cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 80 Brazil cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 81 Brazil cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 82 Brazil cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 83 Mexico cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 84 Mexico cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 85 Mexico cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 86 Mexico cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 87 Argentina cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 88 Argentina cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 89 Argentina cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 90 Argentina cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 91 MEA cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 92 MEA cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 93 MEA cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 94 MEA cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 95 MEA cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 96 South Africa cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 97 South Africa cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 98 South Africa cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 99 South Africa cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 100 Saudi Arabia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 101 Saudi Arabia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 102 Saudi Arabia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 103 Saudi Arabia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 104 UAE cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 105 UAE cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 106 UAE cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 107 UAE cellular health screening market, by collection site, 2018 to 2030 (USD Million)

List of Figures

  • Fig. 1 Cellular health screening market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Cellular health screening market snapshot (2021)
  • Fig. 9 Cellular health screening market: Segment snapshot (2021)
  • Fig. 10 Competitive Insights (2021)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Cellular health screening market driver impact
  • Fig. 15 Cellular health screening market restraint impact
  • Fig. 16 Cellular health screening market industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2021
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by test type
  • Fig. 24 Test type market share analysis, 2021 & 2030
  • Fig. 25 Segment dashboard
  • Fig. 26 Global cellular health screening market, by test type, 2018 - 2030 (USD Million)
  • Fig. 27 Single test panels market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Telomere tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Oxidative stress tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Inflammation tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Heavy metals tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Multi-test panels market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Definition and scope, by sample type
  • Fig. 34 Sample Type market share analysis, 2021 & 2030
  • Fig. 35 Segment dashboard
  • Fig. 36 Global cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Fig. 37 Blood market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Saliva market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Serum market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 Urine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Definition and scope, by collection site
  • Fig. 42 Collection site market share analysis, 2021 & 2030
  • Fig. 43 Segment dashboard
  • Fig. 44 Global cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Fig. 45 Home market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Office market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Hospital market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Diagnostic labs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Cellular health screening market: Snapshot, 2021
  • Fig. 50 North America cellular health screening market share and leading players, 2021
  • Fig. 51 Europe cellular health screening market share and leading players, 2021
  • Fig. 52 Asia Pacific cellular health screening market share and leading players, 2021
  • Fig. 53 Latin America cellular health screening market share and leading players, 2021
  • Fig. 54 Middle East and Africa cellular health screening market share and leading players, 2021
  • Fig. 55 North America market share analysis by country, 2021
  • Fig. 56 Europe market share analysis by country, 2021
  • Fig. 57 Asia Pacific market share analysis by country, 2021
  • Fig. 58 Latin America market share analysis by country, 2021
  • Fig. 59 Middle East and Africa market share analysis by country, 2021
  • Fig. 60 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 61 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 62 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 63 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 64 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 65 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 66 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 67 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 68 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 U.K. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 71 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 72 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 73 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 74 Russia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 78 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 Singapore market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 83 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 84 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 85 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 86 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 87 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 88 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 89 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)